openPR Logo
Press release

EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Clinical Trials Assessment 2024: FDA Approvals, Pipeline, Therapies, MOA, ROA and Companies by DelveInsight | Kairos Pharma (ENV105), Daiichi Sankyo, AbbVie, Akeso, Cullinan Oncology, EpimAb

08-01-2024 06:07 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Clinical Trials

EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Clinical Trials

(Albany, USA) As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 42+ pipeline drugs in the EGFR-Positive Non-Small Cell Lung Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the EGFR-Positive Non-Small Cell Lung Cancer Therapeutics Market.

The report provides a detailed description of the EGFR-Positive Non-Small Cell Lung Cancer drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the EGFR-Positive Non-Small Cell Lung Cancer Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing EGFR-Positive Non-Small Cell Lung Cancer therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for EGFR-Positive Non-Small Cell Lung Cancer treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging EGFR-Positive Non-Small Cell Lung Cancer drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the EGFR-Positive Non-Small Cell Lung Cancer treatment market.

Learn More about the Clinical and Commercial Development Activities in the EGFR-Positive Non-Small Cell Lung Cancer Therapeutics Domain @
https://www.delveinsight.com/report-store/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Therapeutics Analysis
Approximately 40+ prominent pharma and biotech companies are actively involved in developing therapies for EGFR-Positive Non-Small Cell Lung Cancer. Among these, Akeso Biopharma stands out as a notable player, with its EGFR-Positive Non-Small Cell Lung Cancer drug candidates advancing to the most advanced stage, namely Phase III.

EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Companies in the Therapeutics Market Include:
Some of the key companies in the EGFR + NSCLC Market include Alpha Biopharma, Daiichi Sankyo Company, Suzhou Puhe Pharmaceutical Technology, Checkpoint Therapeutics, AbbVie, Akeso Biopharma, Cullinan Oncology, Betta Pharmaceuticals, EpimAb Biotherapeutics, Genor Biopharma, G1 Therapeutics, JIntsBio, and many others.

Emerging and Marketed EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Therapies Covered in the Report Include:
• AK112: Akeso Biopharma
• CLN-081: Cullinan Oncology
• BPI-361175: Betta Pharmaceuticals
• JANX008: Janux Therapeutics
• ENV105: Kairos Pharma
And Many More

Get an in-depth Assessment of the Emerging Therapies and EGFR-Positive Non-Small Cell Lung Cancer Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

The Report Covers the Emerging EGFR-Positive Non-Small Cell Lung Cancer Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
EGFR-Positive Non-Small Cell Lung Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy

Request for Sample PDF to Understand More About the EGFR-Positive Non-Small Cell Lung Cancer Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
1. Report Introduction
2. Executive Summary
3. EGFR-Positive Non-Small Cell Lung Cancer Current Treatment Patterns
4. EGFR-Positive Non-Small Cell Lung Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. EGFR-Positive Non-Small Cell Lung Cancer Late-Stage Products (Phase-III)
7. EGFR-Positive Non-Small Cell Lung Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. EGFR-Positive Non-Small Cell Lung Cancer Discontinued Products
13. EGFR-Positive Non-Small Cell Lung Cancer Product Profiles
14. EGFR-Positive Non-Small Cell Lung Cancer Companies
15. EGFR-Positive Non-Small Cell Lung Cancer Drugs
16. Dormant and Discontinued Products
17. EGFR-Positive Non-Small Cell Lung Cancer Unmet Needs
18. EGFR-Positive Non-Small Cell Lung Cancer Future Perspectives
19. EGFR-Positive Non-Small Cell Lung Cancer Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• Adrenal Insufficiency Market: https://www.delveinsight.com/report-store/adrenal-crisis-market
• Antibody Mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Antibody-mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Bone And Joint Infection Market: https://www.delveinsight.com/report-store/prosthetic-joint-infection-market
• Cholangiocarcinoma Market: https://www.delveinsight.com/report-store/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast
• Cutaneous Lupus Erythematosus Market: https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-market
• Human Papillomavirus Positive Cancer Market: https://www.delveinsight.com/report-store/human-papillomavirus-16-positive-hpv16-cancers-market
• Italy Healthcare Outlook Report: https://www.delveinsight.com/report-store/italy-healthcare-outlook-report
• Postmenopausal Vaginal Atrophy Market: https://www.delveinsight.com/infographics/atrophic-vaginitis-market
• Severe Hypertriglyceridemia Market: https://www.delveinsight.com/report-store/severe-hypertriglyceridemia-shtg-market
• Abscess Market: https://www.delveinsight.com/report-store/abscess-market
• Acute Ischemic Stroke Ais Market: https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
• Adrenoleukodystrophy Market: https://www.delveinsight.com/blog/adrenoleukodystrophy-market-size
• Cutaneous T-cell Lymphoma Market: https://www.delveinsight.com/infographics/cutaneous-t-cell-lymphoma-ctcl-market
• Diffuse Cutaneous Systemic Sclerosis Market: https://www.delveinsight.com/report-store/diffuse-cutaneous-systemic-sclerosis-dcssc-market
• Lhon Market: https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
• Uncomplicated Urinary Tract Infections Market: https://www.delveinsight.com/report-store/uncomplicated-urinary-tract-infection-uuti-market
• Ataxia Telangiectasia Market: https://www.delveinsight.com/report-store/ataxia-telangiectasia-at-market
• Atypical Hemolytic Uremic Syndrome Ahus Market: https://www.delveinsight.com/report-store/atypical-hemolytic-uremic-syndrome-ahus-market
• Biliary Atresia Market: https://www.delveinsight.com/report-store/biliary-atresia-market
• Biliary Tract Cancer Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Inducible Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Chronic Refractory Gout Market: https://www.delveinsight.com/report-store/chronic-refractory-gout-market
• Diffuse Large B-cell Lymphoma Market: https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
• Myelofibrosis Market: https://www.delveinsight.com/report-store/myelofibrosis-mf-market
• Severe Hypoglycemia Market: https://www.delveinsight.com/report-store/severe-hypoglycemia-market
• Ankylosing Spondylitis Bekhterevs Disease Market: https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-market
• Cutaneous T Cell Lymphoma Market: https://www.delveinsight.com/infographics/cutaneous-t-cell-lymphoma-ctcl-market
• Epidermolysis Bullosa Market: https://www.delveinsight.com/report-store/epidermolysis-bullosa-market
• Idiopathic Membranous Nephropathy Market: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-imn-market
• Sjogren's Syndrome Market: https://www.delveinsight.com/report-store/sjogrens-syndrome-market-size
• Balloon Catheters Market: https://www.delveinsight.com/report-store/balloon-catheters-market
• Balloon Catheters Market Market: https://www.delveinsight.com/report-store/balloon-catheters-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
• Community-acquired Bacterial Pneumonia Market: https://www.delveinsight.com/report-store/community-acquired-bacterial-pneumonia-cabp-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Achromatopsia Market: https://www.delveinsight.com/report-store/achromatopsia-market
• Atopic Keratoconjunctivitis Akc Market: https://www.delveinsight.com/report-store/atopic-keratoconjunctivitis-market
• Bipolar Depression Market: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market
• Cardiac Insufficiency Market: https://www.delveinsight.com/report-store/congestive-heart-failure-market
• Chronic Pain Associated With Painful Diabetic Neuropathy Market: https://www.delveinsight.com/blog/chronic-pain-associated-with-painful-diabetic-neuropathy-market
• Tim-3-next Generation Immunotherapy Market: https://www.delveinsight.com/infographics/tim-3-next-generation-immunotherapy-competitive-landscape
• Asmd Market: https://www.delveinsight.com/report-store/acid-sphingomyelinase-deficiency-asmd-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Cardiac Amyloidosis Market: https://www.delveinsight.com/report-store/al-amyloidosis-market
• Healthcare Pipeline Analysis: https://www.delveinsight.com/consulting/pipeline-assessment-services
• Hepatitis D Market: https://www.delveinsight.com/report-store/hepatitis-d-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Endoscopy Fluid Management Systems Market: https://www.delveinsight.com/blog/endoscopy-fluid-management-systems-market
• Helicobacter Pylori Infection Market: https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Clinical Trials Assessment 2024: FDA Approvals, Pipeline, Therapies, MOA, ROA and Companies by DelveInsight | Kairos Pharma (ENV105), Daiichi Sankyo, AbbVie, Akeso, Cullinan Oncology, EpimAb here

News-ID: 3606265 • Views:

More Releases from DelveInsight Business Research

Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 12.80% by 2032, Evaluates DelveInsight
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates DelveInsight
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million by 2032 at a CAGR of 6.91% by 2032, Evaluates DelveInsight
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth. DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices

All 5 Releases


More Releases for Market:

Sorbitol Market Forecast, Sorbitol Market Analysis, Sorbitol Market Growth, Sorb …
The Sorbitol Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market. This report
Esterquats Market, Esterquats Market Size, Esterquats Market Share, Esterquats M …
The "Esterquats Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political,
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview: The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned? In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects. The International Technology Roadmap for Semiconductors (ITRS) has emphasized
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by